← Open Payments lookup

MATTHEW GLENN: Open Payments

NPI 1225080419 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,892 in 114 payments from 22 companies in 2025. Trend: 2023 $2,504 · 2024 $2,103 · 2025 $1,892

Food & beverage: $1,892
CompanyPaymentsAmount
Novo Nordisk Inc15$362
ABBVIE INC.21$330
PFIZER INC.14$219
AstraZeneca Pharmaceuticals LP4$161
Amgen Inc.16$157
Otsuka America Pharmaceutical, Inc.13$152
Axsome Therapeutics, Inc.6$91
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$71
Antares Pharma, Inc.3$50
Boehringer Ingelheim Pharmaceuticals, Inc.2$38

Products named: Wegovy, VRAYLAR, REXULTI, OTEZLA, NURTEC ODT, FARXIGA, QULIPTA, XIFAXAN.

Industry payments across NE — which companies pay providers there.